These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9519797)

  • 21. Effects of ritanserin on haloperidol-induced dopamine (D2) receptor up-regulation in the rat.
    Szczepanik AM; Wilmot CA
    Neurosci Lett; 1997 Aug; 231(2):91-4. PubMed ID: 9291148
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic nicotine use blocks haloperidol-induced increase in striatal D2-dopamine receptor density.
    Prasad C; Spahn SA; Ikegami H
    Biochem Biophys Res Commun; 1989 Feb; 159(1):48-52. PubMed ID: 2522303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dopaminergic dysfunction in neonatal hypothyroidism: differential effects of GM1 ganglioside.
    Vaccari A; Stefanini E; de Montis G; Rossetti ZL
    Neuropharmacology; 1990 Dec; 29(12):1161-9. PubMed ID: 2149873
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment with GM1 ganglioside restores striatal dopamine in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse.
    Hadjiconstantinou M; Neff NH
    J Neurochem; 1988 Oct; 51(4):1190-6. PubMed ID: 3262149
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of a partial D2-like receptor agonist on striatal dopamine autoreceptor functioning in preweanling rats.
    Yoshida ST; Baella SA; Stuebner NM; Crawford CA; McDougall SA
    Brain Res; 2006 Feb; 1073-1074():269-75. PubMed ID: 16427034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GM1 ganglioside treatment promotes recovery of electrically-stimulated [3H]dopamine release in striatal slices from rats lesioned with kainic acid.
    Raiteri M; Bonanno G; Pende M; Versace P
    Neurosci Lett; 1992 Feb; 136(1):127-30. PubMed ID: 1321965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sensitivity of dopamine D2 receptors following long-term treatment with roxindole.
    Seyfried CA; Bartoszyk GD
    Eur J Pharmacol; 1994 May; 257(1-2):67-72. PubMed ID: 7915991
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ganglioside interactions with the dopaminergic system of rats.
    Tilson HA; Harry GJ; Nanry K; Hudson PM; Hong JS
    J Neurosci Res; 1988; 19(1):88-93. PubMed ID: 3125345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of monosialoganglioside on dopaminergic supersensitivity.
    Vital MA; Frussa-Filho R; Palermo-Neto J
    Life Sci; 1995; 56(26):2299-307. PubMed ID: 7791517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of L-deprenyl treatment, alone and combined with GM1 ganglioside, on striatal dopamine content and substantia nigra pars compacta neurons.
    Rothblat DS; Schneider JS
    Brain Res; 1998 Jan; 779(1-2):226-30. PubMed ID: 9473679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The PDE10A inhibitor MP-10 and haloperidol produce distinct gene expression profiles in the striatum and influence cataleptic behavior in rodents.
    Gentzel RC; Toolan D; Roberts R; Koser AJ; Kandebo M; Hershey J; Renger JJ; Uslaner J; Smith SM
    Neuropharmacology; 2015 Dec; 99():256-63. PubMed ID: 26044638
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transient decrease in rat striatal D2 dopamine receptor mRNA level after acute haloperidol treatment.
    Sakata M; Prasad C
    Brain Res Mol Brain Res; 1992 Jul; 14(3):282-4. PubMed ID: 1331654
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic haloperidol affects striatal D2-dopamine receptor reappearance after irreversible receptor blockade.
    Pich EM; Benfenati F; Farabegoli C; Fuxe K; Meller E; Aronsson M; Goldstein M; Agnati LF
    Brain Res; 1987 Dec; 435(1-2):147-52. PubMed ID: 2962698
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of melatonin on behavioral dopaminergic supersensitivity.
    Abílio VC; Vera JA; Ferreira LS; Duarte CR; Martins CR; Torres-Leite D; Ribeiro Rde A; Frussa-Filho R
    Life Sci; 2003 May; 72(26):3003-15. PubMed ID: 12706487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of acute and chronic treatments with clozapine and haloperidol on serotonin (5-HT2) and dopamine (D2) receptors in the rat brain.
    Wilmot CA; Szczepanik AM
    Brain Res; 1989 May; 487(2):288-98. PubMed ID: 2525063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activity-dependent reduction of dopamine D2 receptors during a postnatal critical period of plasticity in rat striatum is not affected by prenatal haloperidol treatment.
    Soiza-Reilly M; Azcurra JM
    Int J Dev Neurosci; 2011 Dec; 29(8):855-60. PubMed ID: 21856408
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of subtype-selective adenosine receptor antagonists on basal or haloperidol-regulated striatal function: studies of exploratory locomotion and c-Fos immunoreactivity in outbred and A(2A)R KO mice.
    Pardo M; López-Cruz L; Valverde O; Ledent C; Baqi Y; Müller CE; Salamone JD; Correa M
    Behav Brain Res; 2013 Jun; 247():217-26. PubMed ID: 23557694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of chronic haloperidol treatment on stimulated synaptic overflow of dopamine in the rat striatum.
    Wiedemann DJ; Garris PA; Near JA; Wightman RM
    J Pharmacol Exp Ther; 1992 May; 261(2):574-9. PubMed ID: 1533666
    [TBL] [Abstract][Full Text] [Related]  

  • 39. EEDQ reduces the striatal neurotensin mRNA response to haloperidol.
    Adams MR; Dobie DJ; Merchant KM; Unis A; Dorsa DM
    Peptides; 1997; 18(4):527-35. PubMed ID: 9210171
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of GM1 ganglioside treatment on dopamine innervation of the striatum of MPTP-treated mice.
    Rothblat DS; Schneider JS
    Ann N Y Acad Sci; 1998 Jun; 845():274-7. PubMed ID: 9668361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.